Changes in sequential coronary arteriograms and subsequent coronary events. Surgical Control of the Hyperlipidemias

H Buchwald1, J P Matts, L L Fitch

  • 1Department of Surgery, University of Minnesota, Minneapolis 55455.

JAMA
|September 16, 1992
PubMed

Insights

Sequential coronary arteriogram changes predict clinical events, offering a prognostic indicator for overall and atherosclerotic coronary heart disease mortality in patients. This aids in atherosclerosis intervention trials.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Interventional Cardiology

Background:

  • Atherosclerosis intervention trials require reliable outcome measures.
  • Sequential coronary arteriograms offer detailed insights into disease progression.

Purpose of the Study:

  • To assess the relationship between changes in sequential coronary arteriograms and subsequent clinical coronary events.
  • To determine if arteriographic changes can serve as surrogate endpoints in atherosclerosis trials.

Main Methods:

  • A randomized trial (Program on the Surgical Control of the Hyperlipidemias) involving 838 patients.
  • Coronary arteriograms were obtained at baseline, 3, 5, and 7/10 years.
  • Blinded assessment of arteriographic changes and correlation with clinical events.

Main Results:

  • Changes in coronary arteriography significantly predicted overall and atherosclerotic coronary heart disease mortality.
  • A strong association was found between arteriographic changes and combined endpoints of mortality or myocardial infarction in both control and surgical groups.
  • Stratified analysis revealed significant differences in clinical events based on disease progression.

Conclusions:

  • Coronary arteriographic changes are a valid surrogate endpoint for specific clinical events in atherosclerosis trials.
  • Arteriographic assessments provide statistically compelling evidence for predicting mortality.
  • Changes in coronary atherosclerosis severity serve as prognostic indicators for individual patients.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...